Michael A. DesJardin - Jan 1, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, Technical Operations
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 1, 2023
Transactions value $
-$1,088,042
Form type
4
Date filed
1/4/2023, 03:25 PM
Previous filing
Dec 29, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +21.8K +26.35% 104K Jan 1, 2023 Direct F1
transaction HZNP Ordinary Shares Tax liability -$1.09M -9.56K -9.16% $113.80 94.8K Jan 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Performance Restricted Stock Units (PSUs) Options Exercise $0 -21.8K -100% $0.00* 0 Jan 1, 2023 Ordinary Shares 21.8K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each PSU represents a contingent right to receive one ordinary share of the Issuer.
F2 The ordinary shares subject to the PSUs vested on January 1, 2023.